Researchers Use C. elegans to Study Aging and Age-Related Diseases

Aging is a universal trait among all organisms. From a public health perspective, with aging comes an increased risk of disease, including Alzheimer’s, cancer and metabolic disease/type II diabetes. Dr. Vilchez (right) and Dr. Koyuncu examining a C. elegans sample. Dr. David Vilchez heads a lab at CECAD, (Cellular Stress Responses in Aging-Associated Diseases), at... Read more

PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease

MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research collaboration with Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, to use the multi-omics capabilities of PacBio’s Sequel IIe system in the study of genetic disease.... Read more

PacBio to Report First Quarter 2022 Financial Results on May 4, 2022

MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2022 financial results on Wednesday, May 4, 2022, at 5:00 pm Eastern Time. The call will be webcast live and may be accessed at PacBio’s website at: https://investor.pacificbiosciences.com/.... Read more

Xylem Invests $5 Million with CNote to Benefit Community Financial Institutions Serving Black and Underserved Communities in the U.S.

Part of Ongoing Commitment to Build a More Sustainable and Equitable Future RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 19, 2022– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today an initial commitment to invest $5 million of its on-hand capital in mission-driven financial institutions that... Read more

Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2022 financial results before market opening on Wednesday, May 4, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go... Read more